Pictured: The EMA building at its old headquarters in London/iStock, Lubo Ivanko The European Medicines Agency has extended its review of a potential suicide risk associated with Novo Nordisk’s Ozempic and Saxenda to other GLP-1 receptor agonists used for weight loss and the treatment of type 2 diabetes. The review was initiated by the Icelandic … Read more
This story is about suicide. If you or someone you know is contemplating suicide, contact the Suicide & Crisis Lifeline at 988 or 1-800-273-TALK (8255). THE popular drugs Ozempic and Saxenda, both made by Novo Nordisk in Denmark, are under investigation after a small number of users experienced an increase in thoughts of suicide and … Read more
A global shortage means some people with diabetes are struggling to access the drug semaglutide, which is sold under the brand name Ozempic. The UK Department of Health and Social Care has recommended that no new patients be started on the drug. Continuing shortages have also been reported in Australia and Ireland. Canada has also … Read more
PHOTO ILLUSTRATION BY Matthew Cooley. PHOTOGRAPHS USED IN ILLUSTRATION FROM Adobe Stock; Getty On social media, the supposed wonder drug that’s on everyone’s lips right now is Ozempic, the drug created to treat type 2 diabetes that’s now being used as a weight-loss treatment. But with access to Ozempic dwindling as demand soars and prices … Read more
